Wednesday · November 18, 2026

 ·  Daily  ·  Newsletters

Resonance network: Quantum InsiderSpace Insider

Business & Markets

Science Corporation Reaches $3.5B Valuation With $400M Series D to Advance Brain Interface Technology

Science Corporation, the neurotechnology startup founded in 2021 by former Neuralink president Max Hodak, has secured $400 million in a Series D round, the company said in a blog post. A person familiar with the deal told TechCrunch the round valued the company at $3.5 billion. Backers included Khosla Ventures, the Ackman Oxman Institute, Tenet Healthcare, 885 Capital, Y Combinator and PLC Neurotech.

Hodak co-founded the company to use new technologies to understand and interact with the brain. Its first product, PRIMA, is a wearable and implantable chip that helps people with age-related macular degeneration regain some vision. The device is approved in Europe, available in Germany, and is now being trialed for Stargardt disease, another cause of blindness.

The new capital will help bring PRIMA to the United States via the FDA’s Humanitarian Device Exemption, after Science persuaded the regulator that advanced macular degeneration in both eyes is rare enough to qualify.

The company’s longer-term goal is connecting directly to the human brain through a bio-hybrid sensor combining cultured neurons and silicon. It is designing initial human trials with Yale neurosurgery professor Murat Günel said the technology could offer potential treatments for Parkinson’s disease and other brain conditions.

James Dargan
About the author
James Dargan

James Dargan is a writer and researcher at The AI Insider. His focus is on the AI startup ecosystem and he writes articles on the space that have a tone accessible to the average reader.

The AI economy, every weekday morning

The daily briefing plus the weekly Scale-ups to watch edition. Free, no spam, unsubscribe any time.